Show an ad over header. AMP

I am the FIRST

Here is what we know so far about Trump's coronavirus infection and treatment

It is very difficult to get a comprehensive, trustworthy read on the severity of President Trump's infection.

What they're saying: Sean Conley, Trump's lead doctor, said all weekend that Trump is doing well and experiencing only relatively minor symptoms. And with its many photo ops, the White House is clearly trying to send the same message.


Yes, but: The details we have about Trump's treatment regimen could call that optimism into question.

  • Trump is now taking the steroid dexamethasone, Conley said Sunday. That drug may help save the lives of seriously ill patients, especially those on ventilators. But it's less effective for patients who are only on supplemental oxygen, and has shown no benefit in the mildest cases.
  • Trump is also receiving two other treatments: remdesivir, which has been shown to reduce hospitalization but not to save seriously ill patients' lives, and an experimental antibody treatment from Regeneron Pharmaceuticals.

Between the lines: The fact that Trump's doctors added dexamethasone to his treatment regimen likely means that they were concerned about his condition deteriorating, possibly because of a drop in his oxygen levels, doctors uninvolved in Trump's treatment told Bloomberg.

"It feels like a whole lot of Kremlinology and I'd just be happier if they’d tell us the truth," University of California, San Francisco medical professor Robert Wachter, told STAT.

regular 4 post ff

infinite scroll 4 pff

Why the startup world needs to ditch "unicorns" for "dragons"

When Aileen Lee originally coined the term "unicorn" in late 2013, she was describing the 39 "U.S.-based software companies started since 2003 and valued at over $1 billion by public or private market investors."

Flashback: It got redefined in early 2015 by yours truly and Erin Griffith, in a cover story for Fortune, as any privately-held startup valued at $1 billion or more. At the time, we counted 80 of them.

Keep reading... Show less

Scoop: Facebook's new moves to lower News Feed's political volume

Facebook plans to announce that it will de-emphasize political posts and current events content in the News Feed based on negative user feedback, Axios has learned. It also plans to expand tests to limit the amount of political content that people see in their News Feeds to more countries outside of the U.S.

Why it matters: The changes could reduce traffic to some news publishers, particularly companies that post a lot of political content.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories